Continue to Site

Endo Health

Boston Scientific and other transvaginal mesh makers defend their devices amid FDA probe

September 12, 2011 By MassDevice staff Leave a Comment

Boston Scientific Corp. (NYSE:BSX) issued an official statement urging the FDA to leave transvaginal mesh products under their current classification, despite growing concerns that the products do more harm than good.

Endo closes the deal with American Medical Systems for $2.9 billion in cash

June 22, 2011 By MassDevice staff Leave a Comment

Endo Pharmaceuticals Holdings Inc. (NSDQ:ENDP), once devoted solely to the drug market, began its foray into medical devices with a successful $2.9 billion cash buyout of American Medical Systems Holdings Inc. (NSDQ:AMMD).

Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup

April 12, 2011 By MassDevice staff Leave a Comment

A company that began life in the pharmaceutical sector is venturing forth into devices in its quest to become a more diversified health care company.

Market Summary > Current Price

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Endo Health

Boston Scientific and other transvaginal mesh makers defend their devices amid FDA probe

Endo closes the deal with American Medical Systems for $2.9 billion in cash

Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup

MASSDEVICE MEDICAL NETWORK

DeviceTalks Webinars, Podcasts, & Discussions

MASSDEVICE

Endo Health

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks Webinars, Podcasts, & Discussions

MASSDEVICE